The author replies below: I take note of the letter from Dr Berry. The trial Dr Berry refers to is the only study that has produced a negative result in relation to the use of homeopathy in arthritic conditions. The comments in my editorial pertaining particularly to the design of studies within homoeopathy are relevant here, in that the study was carried out by conventional physicians and the methodology was poor. While I accept that there is no perfect clinical trial, Dr Berry must realize that there were major methodological problems with his study, and that it is the only negative study so far reported in the field of rheumatology. Inevitably there will be negative studies in homoeopathy, as there are in conventional medicine. This does not, however, justify his comment.
I have tried to illustrate with the aid of three seminal papers that the case for homeopathy is answered clearly, conclusively, and in an elegant scientific manner. I could have referred to many more equally good studies, but you simply would not have had space to print the information! The scientific evidence is, I am afraid, clear. Homeopathic medicines have a greater effect than placebo. This cannot be negated by the odd negative study, which is statistically inevitable. However the case for homeopathy clearly remains unanswered in Dr Berry's mind, in spite of evidence to the contrary, and there is little I can do about that. May I add an argument out of my own experience in the treatment of recurrent herpes; for 5 years, we treated patients suffering oral or genital recurrent herpes (50 cases) by the so-called blood isotherapy, which is giving them once a day for 6 months high dilutions (15 Clf) of their own blood as oral granules prepared by Boiron LHF Laboratory in Bordeaux. With such a treatment, the local crises disappeared or became shorter (2 days long) after the interruption of the treatment: then the patients were told to reactivate the therapic effect by a new treatment for a week.
The well-known symptomatology of recurrent herpes and the great simplicity of this method would allow everyone to improve its efficiency and to get a new knowledge of that enigmatic therapy. Motivation to change Dr West and Mrs Hulse (October 1990 JRSM p 672) raise important questions concerning the health of the nation and the management of change. We must accept that the springs to good health are: knowledge; understanding; responsibility; and education and information.
Modern management theory uses the term motivation both as a tool and a skill. It is therefore interesting that in a meeting report (October 1990 JRSM, p 664, 'Diet and Diabetes') Dr Lean introduces a very useful analogy of motivation for the treatment of obesity.
We have been aware in medical sciences for many decades/centuries that motivation is implicit in good medical management. Dr Lean proposes the use of the buddy concept (well exploited in the psychological management of AIDS patients and smokers) to expand the medical care team.
One only has to look at the need to change and accept responsibility for one's own medical future, to show that effective medical care and health can be accomplished.
It is perhaps because medicine has become more of a science than an art, that techniques first used in the early history of medicine have fallen into disuse. The dynamics of the health market are such that resource management beyond the 'professional' has to be introduced. The local management of major conditions such as CHD changes with the family and colleague matrix taking priority.
The established confidential matrix of patient, physician and nurse has now to be broken. The care in the community has solid foundations in good health management. J STEPHENSON
Medical and Media Communications
75n9 York Road, London SEl 7NP Lifeline and longevity I offer the following criticisms of the 'research' into 'Relationship between longevity and lifeline' (August 1990 JRSM, p 499) (1) I have no objections to the procedure used nor to the manner in which the research was done except to say that the sample used was far too small on which to base such far-reaching conclusions.
(2) My criticisms lie with the premises on which the research was based and more importantly the conclusions which have been drawn. (a) firstly the authors have not researched 'palmistry' in any depth whatsoever. The authors they cite should not be treated as 'experts' no matter how famous they may be. They should be advised to read the more reliable and scientific authors on this subject. (b) The report makes no analysis of the variations in form, quality, location, markings and destination of the 'lifeline'. The authors have received no training in Cheirological analysis of the hand and it is my experience that it is very easy for the untrained eye to make mistakes in assessing the lineation of the palm. We cannot therefore be sure which line it is they have measured. (c) That they have found some statistical correlation between the length of the line and age at death may have some diagnostic value, for pathologists and forensic scientists, but cannot have the prognostic and prophylactic benefits the authors claim. They have only found a correlation for dead people; it is erroneous to conclude that this can have any significance for living people at all, This really is merely a point of logic; but it should also be pointed out here that the lines of the hand are subject to great deal of change within a living person. Whilst it is not yet fully understood how the lines on the hand do form or change, it is quite certain that they are not formed by 'folding' nor
